Matti Aapro

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Chemotherapy Induced

Small Cell Lung Cancer

Patient Reported

Top Venues

European journal of cancer care

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru E Eniu
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes. JMIR cancer 10 (2024)
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru E Eniu
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes. JMIR cancer 10 (2024)
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru E Eniu
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes. JMIR cancer 10 (2024)
Matti Aapro, Stefano Fogli, Bart J Morlion, Romano Danesi
Opioid metabolism and drug-drug interaction in cancer. The oncologist (2024)
Laurent Zelek, Rudolph M Navari, Matti Aapro, Florian Scotte
Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy. Cancer medicine (2023)
Matti Aapro, Florian Scotte, Yolanda Escobar, Luigi Celio, Richard Berman, Alessandra Franceschetti, Danielle Bell, Karin Jordan
Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data. The oncologist 26 (6) (2021)
Nicholas Pavlidis, Fedro Alessandro Peccatori, Alex Eniu, Matti Aapro, Elie Rassy, Franco Cavalli, Alberto Costa
Educational contribution of the College of the European School of Oncology to the Latin American Oncologists. Future oncology (London, England) 17 (23) (2021)
Pere Gascon, Andriy Krendyukov, Nicola Mathieson, Maja Natek, Matti Aapro
Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 33 (6) (2020)
Matti Aapro, Andriy Krendyukov, Nadja Höbel, Pere Gascon
Treatment patterns and outcomes in patients with non-small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropaenia: Results from the MONITOR-GCSF study. European journal of cancer care 28 (4) (2019)
Matti Aapro, Pierfrancesco Ruffo, Roger Panteri, Stefano Costa, Vittoria Piovesana
Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based survey. Cancer reports (Hoboken, N.J.) 1 (4) (2018)